Table 1.
Hepatic function panel results before and after levofloxacin administration.
| Test | Unit | Reference | Days after admission | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | |||
| Albumin | mg/dL | 3.5–5.7 | 3.9 | – | – | 3.3 | 3.3 | 3.8 | 3.7 | 3.4 | 3.7 |
| Protein, Total | mg/dL | 6.0–8.9 | 6.7 | – | – | 5.4 | 5.7 | 6.4 | 6.4 | 5.7 | 6.0 |
| Alkaline Phos. | IU/L | 34–104 | 175 | – | – | 129 | 167 | 207 | 269 | 233 | 232 |
| ALT | IU/L | 7–52 | 24 | – | – | 76 | 171 | 364 | 1100 | 773 | 619 |
| AST | IU/L | 13–39 | 59 | – | – | 188 | 314 | 665 | 1626 | 632 | 305 |
| Bilirubin, Total | mg/dL | 0.3–1.0 | 0.5 | – | – | 0.3 | 0.3 | 0.4 | 0.6 | 0.7 | 0.6 |
| Bilirubin, Direct | mg/dL | 0.0–0.2 | – | – | – | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 |
| Bilirubin, Indirect | mg/dL | 0.0–0.8 | – | – | – | 0.2 | 0.2 | 0.3 | 0.4 | 0.5 | 0.4 |
| Antibiotics administered | |||||||||||
| Levofloxacin Administered days 2–5 | |||||||||||
| Clindamycin Administered days 0–4 | |||||||||||
ALT – alanine transaminase; AST – aspartate transaminase (AST).